VAERS reports by lot

Moderna COVID-19 lot 030LZ0A: VAERS reports

29 VAERS reports list lot 030LZ0A as a Moderna COVID-19 vaccine, received between 2021-01-21 and 2022-01-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
10%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3020%
Neurological2416%
Musculoskeletal1912%
Injection-site / Local reaction1812%
Gastrointestinal1510%
Dermatological (non-injection-site)1510%
Cardiac / Cardiovascular149%
Respiratory75%
Psychiatric / Neuropsychiatric53%
Allergic / Anaphylactic43%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Oklahoma4
Pennsylvania4
Indiana3
New York2
Utah2
Idaho2
Puerto Rico1
California1
Georgia1
New Mexico1
U.S. Virgin Islands1
Alabama1

Reports by month received

2021-017
2021-0210
2021-032
2021-041
2021-051
2021-072
2021-085
2022-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.